Investment analysts at StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a research report issued on Saturday. The firm set a “sell” rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Stock Performance
Aeterna Zentaris stock opened at $3.22 on Friday. The company’s fifty day moving average price is $3.08 and its 200 day moving average price is $4.14. Aeterna Zentaris has a 1 year low of $3.96 and a 1 year high of $12.00. The stock has a market capitalization of $5.77 million, a P/E ratio of -0.22 and a beta of 1.55.
Aeterna Zentaris Company Profile
Read More
- Five stocks we like better than Aeterna Zentaris
- Where Do I Find 52-Week Highs and Lows?
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Most active stocks: Dollar volume vs share volume
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Why Are Stock Sectors Important to Successful Investing?
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.